Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study

By sjmartinez • October 4, 2024

Syal G, Mishkin DS, Banty A, Lee S, Fontelera N, Hampton M, Ziring D, Fleshner PR, Melmed GY. Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study. Inflamm Bowel Dis. 2024 Oct 3;30(10):1907-1910. doi: 10.1093/ibd/izad191. PMID: 37898112.

Tags: calprotectin, Cedars Sinai DoM, chronic pouchitis, Digestive Diseases, modified pouch disease activity index, Publications, tofacitinib

Related Posts

Serum Potassium Monitoring Using AI-Enabled Smartwatch Electrocardiograms

Chiu IM, Wu PJ, Zhang H, Hughes JW, Rogers AJ, Jalilian L, Perez M, Lin CR, Lee CT, Zou J, Ouyang D. Serum Potassium Monitoring[...]

Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height

Hawkes G, Beaumont RN, Li Z, Mandla R, Li X, Albert CM, Arnett DK, Ashley-Koch AE, Ashrani AA, Barnes KC, Boerwinkle E, Brody JA, Carson[...]

Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations

Liu S, Zhu J, Zhong H, Wu C, Xue H, Darst BF, Guo X, Durda P, Tracy RP, Liu Y, Johnson WC, Taylor KD, Manichaikul[...]